Nirav Dhanesha and LSU Health Shreveport Team Discover Neutrophil Integrin α9 as a Key Target in Subarachnoid Hemorrhage Recovery
Nirav Dhanesha, Assistant Professor at the Louisiana State University, shared an important post on LinkedIn:
“Excited to share our latest research on subarachnoid hemorrhage SAH! Our study in Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) reveals a novel role for neutrophil integrin α9 ITGA9 in sensorimotor and cognitive recovery after SAH.
We found that targeting ITGA9, which is expressed on neutrophils, significantly reduces inflammation and neuronal apoptosis. This leads to improved long-term outcomes after SAH.
Huge congratulations to the first author, Harpreet Kaur, Ph.D. for her outstanding work and dedication to this project! Her dedication was instrumental in the success of this study.
Special thanks to all the co-authors Arif Yurdagul Oren Rom, PhD, RD Wayne Orr Mohammad Alfrad Nobel Bhuiyan, PhD Rajesh Mohandas Ajit Vikram Kevin Murnane Xiao-Hong Lu for their invaluable support and collaborative spirit. This was a true team effort! LSU Health Shreveport”
Read the article here:
Article: Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage
Authors: Harpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, Nirvana Shaaban, Dhananjay Kumar, Rajan Pandit, Alexa Martinez, Sumit Kumar Anand, Sandeep Das, Sumati Rohilla, Fabio Arias, Erika Reece, Ravinder Reddy Gaddam, Kevin S. Murnane, Ajit Vikram, Rajesh Mohandas, Xiaolu Zhang, Mohammad Alfrad Nobel Bhuiyan, Xiao-Hong Lu, A. Wayne Orr, Oren Rom, Arif Yurdagul Jr, Nirav Dhanesha
Follow the latest insights in hematology with Hemostasis Today.
-
Mar 7, 2026, 16:24Kalpana Gupta Shekhawat: The Overlooked Regulator of Mast Cells – Understanding the Vagus Nerve
-
Mar 7, 2026, 16:20Purusotham Chippala: How DALYs Reveal the True Burden of Stroke
-
Mar 7, 2026, 16:13Ilenia Calcaterra: Patient-Level Real-World Outcomes of Emicizumab in Acquired Hemophilia A
-
Mar 7, 2026, 16:05Iyas Daghlas: DOACs Use, Genetic Reduction of Coagulation Factors and Risk of Cerebral Venous Thrombosis
-
Mar 7, 2026, 15:58Aurelio Maggio: The Mission and The Projects We Are Advancing for Rare Hematologic Diseases
-
Mar 7, 2026, 15:52Faizan Khan: The Importance of Cancer Site in Bleeding Risk Stratification for Cancer-Associated VTE
-
Mar 7, 2026, 15:50Heghine Khachatryan: How DOACs Can Cause False-Positive FVIII Inhibitor Results
-
Mar 7, 2026, 15:43Gevorg Tamamyan Joins The London Global Cancer Week Steering Group
-
Mar 7, 2026, 15:36Kenneth Monaghan: Empowering Stroke Survivors’ Self-Efficacy Through Neuroplasticity and Daily Activity